BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 7676497)

  • 21. Human cytomegalovirus and Epstein-Barr virus infections occurring early after transplantation are risk factors for antibody-mediated rejection in heart transplant recipients.
    Saldan A; Mengoli C; Sgarabotto D; Fedrigo M; Angelini A; Feltrin G; Gambino A; Gerosa G; Barzon L; Abate D
    Front Immunol; 2023; 14():1171197. PubMed ID: 37256129
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Epstein-Barr virus and disease activity in multiple sclerosis.
    Buljevac D; van Doornum GJ; Flach HZ; Groen J; Osterhaus AD; Hop W; van Doorn PA; van der Meché FG; Hintzen RQ
    J Neurol Neurosurg Psychiatry; 2005 Oct; 76(10):1377-81. PubMed ID: 16170080
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Occurrence of cytomegalovirus infection and factors causing reactivation of the infection among renal transplant recipients: a single center study.
    Khameneh ZR
    Saudi J Kidney Dis Transpl; 2008 Jan; 19(1):41-5. PubMed ID: 18087121
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Epstein-Barr virus antibodies and risk of multiple sclerosis: a prospective study.
    Ascherio A; Munger KL; Lennette ET; Spiegelman D; Hernán MA; Olek MJ; Hankinson SE; Hunter DJ
    JAMA; 2001 Dec; 286(24):3083-8. PubMed ID: 11754673
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Features of Epstein-Barr Virus and Cytomegalovirus Reactivation in Acute Leukemia Patients After Haplo-HCT With Myeloablative ATG-Containing Conditioning Regimen.
    Ru Y; Zhu J; Song T; Ding Y; Zhu Z; Fan Y; Xu Y; Sun A; Qiu H; Jin Z; Tang X; Han Y; Fu C; Chen S; Ma X; Chen F; Chen J; Wu D
    Front Cell Infect Microbiol; 2022; 12():865170. PubMed ID: 35651756
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Measurement of EBV-IgG anti-VCA avidity aids the early and reliable diagnosis of primary EBV infection.
    Robertson P; Beynon S; Whybin R; Brennan C; Vollmer-Conna U; Hickie I; Lloyd A
    J Med Virol; 2003 Aug; 70(4):617-23. PubMed ID: 12794726
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Differential Reactivation of Cytomegalovirus and Epstein-Barr Virus in Patients with B Cell Lymphoma.
    Hatayama Y; Watanabe K; Ichikawa H; Kawamura K; Fukuda T; Motokura T
    Viral Immunol; 2023 Oct; 36(8):520-525. PubMed ID: 37440168
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Choice of antibody immunotherapy influences cytomegalovirus viremia in simultaneous pancreas-kidney transplant recipients.
    Huurman VA; Kalpoe JS; van de Linde P; Vaessen N; Ringers J; Kroes AC; Roep BO; De Fijter JW
    Diabetes Care; 2006 Apr; 29(4):842-7. PubMed ID: 16567825
    [TBL] [Abstract][Full Text] [Related]  

  • 29. ICAM-1, soluble-CD23, and interleukin-10 concentrations in serum in renal-transplant recipients with Epstein-Barr virus reactivation.
    Hornef MW; Bein G; Wilhelm D; Fricke L; Kirchner H
    Clin Diagn Lab Immunol; 1997 Sep; 4(5):545-9. PubMed ID: 9302203
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Simulect and HHV-6 in pediatric renal transplantation.
    Acott PD; Crocker JF; Lee S
    Transplant Proc; 2004 Mar; 36(2 Suppl):483S-486S. PubMed ID: 15041393
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Is screening for IgG antibody to cytomegalovirus and Epstein-Barr virus infections mandatory in potential renal transplant recipients and donors in Iran?
    Saghafi H; Qorashi M; Heidari A
    Transplant Proc; 2009 Sep; 41(7):2761-3. PubMed ID: 19765428
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Time course and frequency of Epstein-Barr virus reactivation after kidney transplantation: linkage to renal allograft rejection.
    Jabs WJ; Maurmann S; Wagner HJ; Müller-Steinhardt M; Steinhoff J; Fricke L
    J Infect Dis; 2004 Nov; 190(9):1600-4. PubMed ID: 15478064
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Serologic follow-up of cytomegalovirus, herpes simplex and varicella-zoster infections in kidney transplant recipients].
    Merlino C
    G Batteriol Virol Immunol; 1991; 84(1-12):41-52. PubMed ID: 1668971
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evaluation the Architect EBV VCA IgM, VCA IgG, and EBNA-1 IgG chemiluminescent immunoassays to assess EBV serostatus prior transplantation.
    Maylin S; Feghoul L; Salmona M; Herda A; Mercier-Delarue S; Simon F; Legoff J
    J Med Virol; 2017 Nov; 89(11):2003-2010. PubMed ID: 28661055
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The efficacy of valganciclovir for prevention of infections with cytomegalovirus and Epstein-Barr virus after kidney transplant in children.
    Cameron BM; Kennedy SE; Rawlinson WD; Mackie FE
    Pediatr Transplant; 2017 Feb; 21(1):. PubMed ID: 27704725
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Incidence of Cytomegalovirus DNAemia in Pediatric Kidney Transplant Recipients After Cessation of Antiviral Prophylaxis.
    Chaiyapak T; Borges K; Williams A; Banh T; Vasilevska-Ristovska J; Allen U; Parekh RS; Hébert D
    Transplantation; 2018 Aug; 102(8):1391-1396. PubMed ID: 29377877
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Early and late virological monitoring of cytomegalovirus, Epstein-Barr virus, and human herpes virus 6 infections in small bowel/multivisceral transplant recipients.
    Petrisli E; Chiereghin A; Gabrielli L; Zanfi C; Lauro A; Piccirilli G; Baccolini F; Altimari A; Bagni A; Cescon M; Pinna AD; Landini MP; Lazzarotto T
    Transplant Proc; 2010; 42(1):74-8. PubMed ID: 20172284
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antibodies to Epstein-Barr virus and cytomegalovirus in relation to CD4 cell number in human immunodeficiency virus 1 infection.
    Quesnel A; Pozzetto B; Touraine F; Moja P; Lucht F; De The G; Touraine JL; Gaudin O; Genin C
    J Med Virol; 1992 Jan; 36(1):60-4. PubMed ID: 1349340
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Epstein-Barr virus and cytomegalovirus in autoimmune diseases: are they truly notorious? A preliminary report.
    Barzilai O; Sherer Y; Ram M; Izhaky D; Anaya JM; Shoenfeld Y
    Ann N Y Acad Sci; 2007 Jun; 1108():567-77. PubMed ID: 17894021
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Reactivations of cytomegalovirus, human herpes virus 6, and Epstein-Barr virus differ with respect to risk factors and clinical outcome after hematopoietic stem cell transplantation.
    Jaskula E; Dlubek D; Sedzimirska M; Duda D; Tarnowska A; Lange A
    Transplant Proc; 2010 Oct; 42(8):3273-6. PubMed ID: 20970670
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.